LEEA ARSENAULT: Open Payments
NPI 1750642062 · TOMS RIVER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$769 in 52 payments from 15 companies in 2025. Trend: 2023 $712 · 2024 $904 · 2025 $769
Food & beverage: $769
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 17 | $142 |
| PFIZER INC. | 6 | $101 |
| Incyte Corporation | 4 | $78 |
| Regeneron Healthcare Solutions, Inc. | 4 | $74 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $55 |
| Lilly USA, LLC | 3 | $55 |
| GENZYME CORPORATION | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 3 | $47 |
| LEO Pharma Inc. | 2 | $37 |
| Galderma Laboratories, L.P. | 2 | $33 |
Products named: CIBINQO, DUPIXENT, OPZELURA, TALTZ, COSENTYX, ILUMYA, LIBTAYO, NEMLUVIO.
Industry payments across NJ — which companies pay providers there.
